23 filings
15-12G
SLRXF
Tribute Pharmaceuticals Canada Inc.
12 Feb 16
Securities registration termination
12:00am
D
SLRXF
Tribute Pharmaceuticals Canada Inc.
5 Feb 16
$75M in equity, sold $75M, 7 investors
12:00am
D
SLRXF
Tribute Pharmaceuticals Canada Inc.
5 Feb 16
$75M in debt / options / securities to be acquired, sold $75M, 3 investors
12:00am
POS AM
SLRXF
Tribute Pharmaceuticals Canada Inc.
5 Feb 16
Prospectus update (post-effective amendment)
12:00am
POS AM
SLRXF
Tribute Pharmaceuticals Canada Inc.
5 Feb 16
Prospectus update (post-effective amendment)
12:00am
POS AM
qbj9cmif6qqjrd9 6iva
5 Feb 16
Prospectus update (post-effective amendment)
12:00am
425
9ix5ooavb9g0719
6 Nov 15
Business combination disclosure
12:00am
D/A
fu801
10 Jun 15
$807.74K in options / securities to be acquired, 2 investors
12:00am
D
b55byd
5 Jun 15
$4.1M in equity, sold $4.1M, 2 investors
12:00am
D
xgb w32mv17
21 Oct 14
$1.12M in options / securities to be acquired, 1 investor
12:00am
D
tbgyxr0o7i4mv2m2u
21 Oct 14
$275.53K in options / securities to be acquired, 2 investors
12:00am
D
cihwhs
21 Oct 14
$6.58M in options / securities to be acquired, 13 investors
12:00am
F-3
7oa5c 99xg2tqn1dt
1 Aug 14
Shelf registration (foreign)
12:00am
424B3
rb334un1cibyw zx0
14 Nov 13
Prospectus supplement
12:00am
424B3
o33ayo9s
14 Aug 13
Prospectus supplement
12:00am
424B3
t6qzwtjwjkrn6 marykp
24 Jun 13
Prospectus supplement
12:00am
S-1
llspm06z9qh57 son
12 Apr 13
IPO registration
12:00am
D
w7ez74
18 Mar 13
$4.27M in equity / options / securities to be acquired, sold $4.27M, 19 investors
12:00am